Ardelyx Inc
NASDAQ:ARDX
| Market Cap (Intraday) | 100.64M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.99 |
| 50-Day MA | $1.18 |
| 200-Day MA | $4.52 |
Ardelyx Inc Stock, NASDAQ:ARDX
34175 Ardenwood Boulevard, Suite 200, Fremont, California 94555
United States of America
Phone: +1.510.745.1700
Number of Employees: 129
Description
Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of cardiorenal diseases. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet on October 17, 2007 and is headquartered in Fremont, CA.